SS Innovations International (NASDAQ: SSII) has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, an honor that recognizes a company demonstrating excellence in innovation, commercial success, industry leadership and positive societal impact, according to a press release issued by the company.
The award underscores the increasing adoption of the company's SSi Mantra surgical robotic system, which SS Innovations believes is gaining traction due to its advanced technology, user-friendly design, training capabilities and cost efficiency. As of June 22, 2026, the company reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system. These include 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. Additionally, approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries.
The recognition from the Surgical Robotics Industry Awards is significant for SS Innovations as it validates the company's strategic direction and technological advancements. The SSi Mantra system is designed to make robotic surgery more affordable and accessible globally, aligning with the company's vision to expand the benefits of robotic surgery to a larger segment of the population. The award also highlights the company's commercial success, as reflected in the growing number of procedures and trained physicians.
For the broader surgical robotics industry, this award signals that cost-effective and user-friendly systems are gaining market acceptance. As more healthcare providers seek to adopt robotic surgery, systems like the SSi Mantra that offer comprehensive training and multi-specialty capabilities may become increasingly important. The company's success in performing 175 telesurgeries also points to the potential for remote surgical applications, which could expand access to specialized care in underserved regions.
The implications for patients and healthcare systems are substantial. With over 11,700 procedures completed, the SSi Mantra system has demonstrated its ability to support a wide range of surgeries, from cardiac to pediatric. The system's cost efficiency could lower barriers to entry for hospitals and clinics, potentially increasing patient access to minimally invasive robotic surgery. Furthermore, the training of 2,100 physicians suggests a growing skilled workforce capable of performing robotic procedures, which could improve surgical outcomes and reduce recovery times.
SS Innovations, an American company headquartered in India, plans to continue expanding the global presence of its surgical robotic solutions. The company's product range includes the SSi Mantra system and the SSi Mudra suite of surgical instruments, which support various procedures including cardiac surgery. More information is available on the company's website at ssinnovations.com.
The press release also includes forward-looking statements and disclaimers. For more details on the award, the full release can be viewed at https://ibn.fm/XWdRe.
